CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-11 | DHILLON AVTAR S Director | Grant or award · Restricted Stock Unit | +8,170 | 8,170 | ||
| 2018-05-08 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion | +23,333 | 2,315,140 | ||
| 2018-05-08 | Kim Jong Joseph Chief Executive Officer | Shares withheld for taxes | −6,646 | $4.68 | $31K | 2,308,494 |
| 2018-05-08 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −23,333 | 0 | ||
| 2018-04-16 | Weiner David B. Director | Sale | −9,000 | $4.91 | $44K | 758,956 |
| 2018-04-13 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion | +107,500 | $2.16 | $232K | 2,399,307 |
| 2018-04-13 | Kim Jong Joseph Chief Executive Officer | Sale | −107,500 | $5.06 | $543K | 2,291,807 |
| 2018-04-13 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion · Common Stock Option | −107,500 | 0 | ||
| 2018-04-12 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion | +103,750 | $2.40 | $249K | 2,395,557 |
| 2018-04-12 | Kim Jong Joseph Chief Executive Officer | Sale | −103,750 | $5.14 | $533K | 2,291,807 |
| 2018-04-12 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion · Common Stock Option | −103,750 | 0 | ||
| 2018-04-12 | BENITO SIMON X Director | Exercise or conversion | +3,750 | $3.56 | $13K | 31,548 |
| 2018-04-12 | BENITO SIMON X Director | Sale | −3,750 | $5.23 | $20K | 27,798 |
| 2018-04-12 | BENITO SIMON X Director | Exercise or conversion · Common Stock Options | −3,750 | 0 | ||
| 2018-03-21 | Bickerstaff George Director | Exercise or conversion | +4,090 | 4,090 | ||
| 2018-03-21 | Bickerstaff George Director | Exercise or conversion · Restricted Stock Unit | −4,090 | 8,180 | ||
| 2018-03-10 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion | +20,434 | 87,166 | ||
| 2018-03-10 | Bagarazzi Mark Chief Medical Officer | Shares withheld for taxes | −5,653 | $4.51 | $25K | 81,513 |
| 2018-03-10 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −20,434 | 40,866 | ||
| 2018-03-10 | KIES PETER CFO | Exercise or conversion | +20,434 | 88,987 |
Page 40 of 49 · 961 trades